Respiratory failure in tetanus - Case report and review of a 25-year experience

被引:18
作者
Bunch, TJ
Thalji, MK
Pellikka, PA
Aksamit, TR
机构
[1] Mayo Clin, Div Pulm & Crit Care Med & Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA
关键词
respiratory; respiratory failure; tetanus;
D O I
10.1378/chest.122.4.1488
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The objectives of the. study were to describe a novel presentation of tetanus and to review the course of the respiratory component and the treatment and management of the disease. A case report is presented with a review of a 25-year experience at Mayo Clinic. We describe the case of a 65-year-old woman who presented with persistent hiccups, dyspnea, and pleurisy of 3 days duration that was caused by tetanus from inadequate secondary immunity. She required intubation for progressive trismus and laryngospasm-associated respiratory failure. Infusion of lorazepam did not control her spasms. Refractory spasms and hiccups resolved with fentanyl and cisatracurium therapy. After 3 weeks, the patient was weaned from the ventilator with complete recovery. In the past 25 years, nine additional patients have presented to Mayo Clinic with acute tetanus. Respiratory failure requiring intubation developed in seven patients, and six of the seven intubated patients survived with minimal deficits. The prognosis of tetanus is favorable if it is diagnosed promptly and if treatment and supportive measures are begun. To our knowledge, this is the first report of a patient with acute tetanus presenting with hiccups. This report also confirms the results of previous studies that suggested a need for improved immunity in the elderly population.
引用
收藏
页码:1488 / 1492
页数:5
相关论文
共 32 条
[1]   Seroprevalence of tetanus antibodies among adults older than 65 years [J].
Alagappan, K ;
Rennie, W ;
Kwiatkowski, T ;
Falck, J ;
Silverstone, F ;
Silverman, R .
ANNALS OF EMERGENCY MEDICINE, 1996, 28 (01) :18-21
[2]   TETANUS - REVIEW [J].
ALFERY, DD ;
RAUSCHER, LA .
CRITICAL CARE MEDICINE, 1979, 7 (04) :176-181
[3]  
ALMADSYAH I, 1985, BRIT MED J, V291, P648
[4]  
Bleck T P, 1991, Dis Mon, V37, P545
[5]   PHARMACOLOGY OF TETANUS [J].
BLECK, TP .
CLINICAL NEUROPHARMACOLOGY, 1986, 9 (02) :103-120
[6]  
Caldwell MB, 1994, MMWR-MORBID MORTAL W, V4, P1
[7]  
Dietz V, 1996, B WORLD HEALTH ORGAN, V74, P619
[8]   Tetanus: Pathophysiology and management [J].
Ernst, ME ;
Klepser, ME ;
Fouts, M ;
Marangos, MN .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (12) :1507-1513
[9]   DANTROLENE IN SEVERE TETANUS [J].
FARQUHAR, I ;
HUTCHINSON, A ;
CURRAN, J .
INTENSIVE CARE MEDICINE, 1988, 14 (03) :249-250
[10]   Tetanus [J].
Farrar, JJ ;
Yen, LM ;
Cook, T ;
Fairweather, N ;
Binh, N ;
Parry, J ;
Parry, CM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (03) :292-301